Skip to main content

Table 2 The pooled results of association between clinical prognosis and MIR31HG expression

From: The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors

Outcomes Studies Participants HRs and 95% CIs Model Heterogeneity
P, I2
OS
 Total 11 1096 1.10 (0.60, 2.03) Random < 0.001, 88.1%
 Gastrointestinal cancer 5 604 0.56 (0.41, 0.77) Random 0.825, 0%
 Lung cancer 3 270 1.64 (1.15, 2.34) Random 0.615, 0%
 Other cancers 3 222 3.37 (2.69, 4.23) Random 0.746, 0%
DFS 2 335 0.44 (0.27, 0.72) Fixed 0.551, 0%
RFS 3 1367 2.54 (1.91, 3.38) Fixed 0.610, 0%
  1. CI confidence interval, DFS disease-free survival, HR hazard ratio, OS overall survival, RFS relapse-free survival